<code id='E2C900505D'></code><style id='E2C900505D'></style>
    • <acronym id='E2C900505D'></acronym>
      <center id='E2C900505D'><center id='E2C900505D'><tfoot id='E2C900505D'></tfoot></center><abbr id='E2C900505D'><dir id='E2C900505D'><tfoot id='E2C900505D'></tfoot><noframes id='E2C900505D'>

    • <optgroup id='E2C900505D'><strike id='E2C900505D'><sup id='E2C900505D'></sup></strike><code id='E2C900505D'></code></optgroup>
        1. <b id='E2C900505D'><label id='E2C900505D'><select id='E2C900505D'><dt id='E2C900505D'><span id='E2C900505D'></span></dt></select></label></b><u id='E2C900505D'></u>
          <i id='E2C900505D'><strike id='E2C900505D'><tt id='E2C900505D'><pre id='E2C900505D'></pre></tt></strike></i>

          knowledge

          knowledge

          author:Wikipedia    Page View:71

          Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.

          advertisement

          For more on what we cover, here’s our full Summit coverage; here’s more on Medicare and GLP-1s; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          comprehensive

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          EU regulator recommends expanding Mounjaro approval to obesity
          EU regulator recommends expanding Mounjaro approval to obesity

          PauloAmorim/VWPicsviaAPImagesLONDON—TwodaysaftersimilardecisionsintheU.S.andU.K.,regulatorsinEuropeo

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

          MollyFerguson/STATHello!SometakesandthoughtsonGilead’sTrodelvytroubles,ElevationOncology’ssurprising